With the COVID-19 outbreak escalating around the world, the hiring outlook of enterprises in Taiwan has weakened to its lowest since 2017, a survey released by online job bank yes123 (yes123人力銀行) showed.
The survey found that about 91.1 percent of the enterprises polled were planning to hire newcomers after the Lunar New Year holiday, down 3.6 percentage points from a similar poll conducted a year earlier, the company said.
This year’s figure is the lowest since 2017, when about 90.9 percent of the employers said they would expand their workforces after the holiday.
Among those employers planning to recruit, the average was 15.6 job openings each, up from 15 in a poll conducted a year earlier.
Of employers that are not planning to expand their workforces, 5.1 percent said they would downsize their operations and 3.8 percent said that they would not fill vacancies if people left the firm.
The spread of COVID-19 has had an adverse impact on domestic demand in Taiwan, as many consumers preferred to stay home in a bid to prevent infection, yes123 spokesman Yang Tsung-pin (楊宗斌) said.
The tourism industry, including hoteliers and airlines, could see a bigger impact, while online shopping and food deliveries could benefit from a trend in which consumers tend to place orders from home, Yang said.
The survey found that 48 percent of respondents said that concerns over COVID-19 are expected to affect their businesses, while 9.4 percent said they are expecting to benefit.
ADJUSTMENTS IN PAY
Compensation offered by employers has also been affected.
The average monthly salaries offered by the polled enterprises to non-management employees stood at NT$33,110, down NT$266, or 0.8 percent, from a similar poll a year earlier.
For management posts, the survey found the average monthly salaries rose NT$146 or NT40.3 percent from a year earlier to NT$51,570.
The survey, conducted from Feb. 5 to Feb. 19, collected 903 valid responses and had a confidence level of 95 percent and a margin of error of plus or minus 3.26 percentage points.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March